The latest price target for Afya (NASDAQ:AFYA) was reported by UBS on August 30, 2024. The analyst firm set a price target for $19.50 expecting AFYA to rise to within 12 months (a possible 19.93% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Afya (NASDAQ:AFYA) was provided by UBS, and Afya initiated their neutral rating.

The last upgrade for Afya Ltd happened on October 13, 2023 when Morgan Stanley raised their price target to $20.5. Morgan Stanley previously had an equal-weight for Afya Ltd.

The last downgrade for Afya Ltd happened on January 22, 2024 when Morgan Stanley changed their price target from $20.5 to $23 for Afya Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Afya, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Afya was filed on August 30, 2024 so you should expect the next rating to be made available sometime around August 30, 2025.

While ratings are subjective and will change, the latest Afya (AFYA) rating was a initiated with a price target of $0.00 to $19.50. The current price Afya (AFYA) is trading at is $16.26, which is within the analyst’s predicted range.